NCT05836571 2025-10-20Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue SarcomaNational Cancer Institute (NCI)Phase 2 Active not recruiting66 enrolled